Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

According to an SEC filing dated November 14, 2025, Bain Capital Life Sciences Investors, LLC sold 122,106 shares of ...

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Merck, the New Jersey-based pharmaceutical giant, will pay Cidara stockholders $221.50 a share in the all-cash deal. Cidara ...

The latest announcement is out from Sosei Group ( (JP:4565) ).

You've disabled cookies in your web browser. A third-party browser plugin, such as Ghostery or NoScript, is preventing ...

Olema OLMA stock fell 7% after-hours following announcement of a public offering of common stock and pre-funded warrants managed by TD Cowen.

Jazz Pharmaceuticals plc stock jumped on positive Ziihera trial results. Click for my updated look at JAZZ stock and see why ...

Investing.com -- Agios Pharmaceuticals (NASDAQ:AGIO) stock fell 12% after the company announced mixed results from its Phase 3 RISE UP trial of mitapivat in sickle cell disease patients.

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

Experts predict short-term volatility due to global factors, though domestic fundamentals suggest potential medium-term gains ...

Olema Pharmaceuticals stock surged 197% after Roche reported positive trial results for a similar breast cancer drug.